BRKR

1 Day 1D

5 Days 5D

1 Month 1M

6 Months 6M

YTD YTD

1 Year 1Y

5 Years 5Y

About Bruker Corp

Bruker is enabling scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker's high-performance scienti c instruments and high-value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular and microscopic levels. In close cooperation with its customers, Bruker is enabling innovation, improved productivity and customer success in life science molecular research, in applied and pharma applications, in microscopy and nanoanalysis, and in industrial applications, as well as in cell biology, preclinical imaging, clinical phenomics and proteomics research and clinical microbiology.
CEO
Frank Laukien
Employees
7400
Headquarters

40 Manning Rd
Billerica, Massachusetts 01821-3915
Phone: 19786633660
www.bruker.com

News

Industry Comparison: Evaluating Agilent Technologies Against Competitors In Life Sciences Tools & Services Industry
Jun 11, 2024 15:00pm

In today''s fast-paced and competitive business landscape, it is essential for investors and industry enthusiasts to thoroughly analyze companies before making investment decisions. In this article, we will conduct a comprehensive industry comparison, evaluating Agilent Technologies (NYSE: A ) against its key competitors in the Life Sciences Tools & Services industry. By examining key financial metrics, market position, and growth prospects, we aim to provide valuable insights for investors and shed light on company''s performance within the industry. Agilent Technologies Background Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent''s measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools, cross lab (consisting of consumables and services related to life science and applied tools), and diagnostics and genomics. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations.


Source:Benzinga
Bruker Launches Transformative neofleX™ MALDI-TOF System for Spatial Biology Mass Spec Imaging (MSI) Applications
Jun 03, 2024 11:17am

neofleX is a versatile, high-performance, and easy-to-use multiomics MSI system for biopharma, translational and clinical researchers neofleX Imaging Profiler MALDI-TOF/TOF with proprietary smartbeam 3D laser neofleX and MALDI HiPLEX-IHC technology enable protein tissue imaging Multiomics MSI correlation of targeted proteins with glycans, metabolites, lipids, endogenous peptides, and now also mid-plex mRNA/DNA-ISH More insights per pixel […] L''articolo Bruker Launches Transformative neofleX™ MALDI-TOF System for Spatial Biology Mass Spec Imaging (MSI) Applications è un contenuto originale di 01net .


Source:01net Italy
Bruker Launches Ultimate Sensitivity timsTOF Ultra 2 to Enable New Research Paradigms in Single-Cell and Subcellular Proteomics
Jun 03, 2024 11:00am

At the 72nd ASMS meeting, Bruker Corporation (Nasdaq: BRKR) launches the new top-of-the-line timsTOF Ultra 2 system with significantly further enhanced sensitivity for deep profiling of small cells, subcellular organelles, as well as increased sample loading flexibility. Together with new Spectronaut 19 software and the novel PreOmics ENRICHplus kit, Bruker is setting new 4D-Proteomics standards Jetzt den vollständigen Artikel lesen


Source:Wallstreet:Online
Bruker Launches Ultimate Sensitivity timsTOF Ultra 2 to Enable New Research Paradigms in Single-Cell and Subcellular Proteomics | BRKR Stock News
Jun 03, 2024 11:00am

Bruker unveils timsTOF Ultra 2 at ASMS 2024, boosting protein group ID by 50% and peptides by 100%. New software enhances data analysis. Read more now!


Source:Stock Titan
Bruker Launches Transformative neofleX MALDI-TOF System for Spatial Biology Mass Spec Imaging (MSI) Applications
Jun 03, 2024 11:00am

At the 72nd ASMS meeting, Bruker Corporation (Nasdaq: BRKR) announced the launch of a novel, high-performance MALDI-TOF/TOF system, the neofleX Imaging Profiler for mass spectrometry-based tissue imaging. It enables facile OME-TIFF file output via the new SCiLS Scope software. The transformative neofleX MALDI-TOF/TOF MSI system now conveniently fits on a bench-top. This press release features Jetzt den vollständigen Artikel lesen


Source:Wallstreet:Online
Bruker: A Confusing Acquisition Spree
May 31, 2024 19:23pm

No summary available.


Source:Seeking Alpha
Salesforce, Nutanix, Bruker among premarket losers'' pack
May 30, 2024 12:25pm

No summary available.


Source:Seeking Alpha
Bruker Announces Pricing of Public Offering of Common Stock | BRKR Stock News
May 30, 2024 00:17am

Bruker (Nasdaq: BRKR) announces public offering of 6M shares to reduce debt from acquisitions; underwriters BofA Securities, J.P. Morgan. Closing expected by May 31, 2024.


Source:Stock Titan
Bruker Announces Pricing of Public Offering of Common Stock
May 30, 2024 00:17am

Bruker Corporation (“Bruker” or the “Company”) (Nasdaq: BRKR) today announced the pricing of its previously announced underwritten registered public offering of 6,000,000 shares of its common stock. Additionally, the Company has granted the underwriters a 30-day option to purchase up to an additional 900,000 shares of its common stock. The offering is expected to close on or about May 31, Jetzt den vollständigen Artikel lesen


Source:Wallstreet:Online
Bruker announces offering of common stock
May 29, 2024 20:26pm

Bruker Corporation announces a public offering of 6M shares of common stock, with an option for underwriters to purchase additional shares.


Source:Seeking Alpha